2 most recent filings and news items mentioning ALKS. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ALKS/news?limit=20"
Pull ALKS filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayAlkermes announced that its investigational narcolepsy and idiopathic hypersomnia treatment alixorexton received orphan drug designations from the FDA and European Commission, providing development incentives and market exclusivity if approved. The designations support the compan
View filing at SEC.gov →Alkermes plc filed an amended 2018 Stock Option and Incentive Plan governing equity awards for officers, employees, directors and consultants. The plan amendment is relevant to investors as it affects executive compensation structure and employee incentive alignment.
View filing at SEC.gov →